GMGN Co-Founder: Web Version Launches a Series of Updates to Enhance Ethereum Mainnet User Experience
BlockBeats news, on April 22, GMGN co-founder Haze posted on X that, driven by the recent meme frenzy on Ethereum mainnet, the GMGN platform is accelerating improvements to the user experience on Ethereum mainnet. The latest updates include the following for the web version:
Eth now supports limit orders/advanced strategies, Eth PnL supports multiple wallets, Eth supports multi-wallet trading, supports continuous click trading, and Eth has completed the first round of acceleration (further optimization is ongoing).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
